Global Plasma Fractionation Market to Reach US$ 39.7 Billion by 2032, Stimulated by Increasing Prevalence of Life-threatening Conditions

October 10, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Plasma Fractionation Market Report by Product (Immunoglobulins, Albumin, Coagulation factor VIII, Coagulation factor IX), Sector (Private Sector, Public Sector), Application (Neurology, Immunology, Hematology, and Others), End User (Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes), and Region 2024-2032,” the global plasma fractionation market size reached US$ 25.1 Billion in 2023. Plasma fractionation is a sophisticated biomedical process for producing various therapeutic products derived from human blood plasma. The technique involves the separation of blood plasma into its constituent components, such as proteins, clotting factors, and immunoglobulins, through a series of fractionation steps. This intricate process transforms plasma into valuable medical products, including albumin, immunoglobulins, clotting factors, and other specialized proteins. These plasma-derived therapies are pivotal in treating various medical conditions, ranging from immune deficiencies and hemophilia to neurological disorders. The therapeutic significance of plasma fractionation lies in harnessing the potency of specific proteins within plasma to develop life-saving medications. Despite its complexity, technological advancements in plasma fractionation have improved efficiency, yield, and safety, producing high-quality, purified products. Plasma fractionation also plays a crucial role in addressing global health challenges by providing therapies for rare diseases and contributing to emergency preparedness, particularly during health crises.

Global Plasma Fractionation Market Trends:

The global market is majorly driven by the growing prevalence of diseases such as immune deficiencies, hemophilia, and autoimmune disorders. In line with this, the increasing demand for plasma-derived therapies is significantly contributing to the market growth. Furthermore, the rising global geriatric population, prone to age-related conditions, contributes significantly to the expanding demand for these therapies. Moreover, technological advancements in plasma fractionation processes enhance production efficiency, ensuring a reliable and high-quality supply of plasma-derived products. Besides, the growing awareness about the importance of plasma donation, coupled with improved screening processes, is increasing the availability of source material for fractionation. The expanding applications of plasma-derived products, extending beyond traditional uses to include treatments for neurological disorders and certain cancers, further stimulate market growth. Additionally, the COVID-19 pandemic has accentuated the importance of plasma-derived therapies, such as convalescent plasma, in addressing emerging health challenges. The strategic role of plasma fractionation in emergency preparedness and its contribution to healthcare solutions for rare diseases also contribute to the market's sustained expansion. Looking forward, the market value is projected to reach US$ 39.7 Billion by 2032, expanding at a CAGR of 5.1% during 2024-2032.

Market Summary:

  • Based on the product, the market has been segmented as Immunoglobulins, Albumin, Coagulation factor VIII, and Coagulation factor IX.
  • On the basis of the sector, the market has been divided as private and public sector.
  • Based on the application, the market has been categorized into neurology, immunology, hematology, and other applications.
  • Based on the end user, the market has been divided into hospitals and clinics, clinical research laboratories, and academic institutes.
  • Region-wise, the market has been segmented into North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd., and Virchow Biotech Private Limited.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Product, Sector, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Plasma Fractionation Market to Reach US$ 39.7 Billion by 2032, Stimulated by Increasing Prevalence of Life-threatening Conditions
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More